# Eurekabio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eurekabio

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.eurekabio.com
- Total disclosed funding: $42M
- Latest round: Series B (Feb 21, 2024)
- Investors on record: 11

## About

Founded in 2014 and based in Shenzhen, China, Eurekabio is a biotech company that focuses on providing cell and gene therapy services. In February 2024, the firm raised a series B+ funding for CNY 300 million. The company has branches in cities such as Shanghai and Hong Kong. It has partnered with companies such as GenScript Biotech and Terumo Bister.

The company's main products include CellSep®? PRO fully enclosed automated cell processing system, EuLV®? system and EuBioX system, etc. CellSep®? PRO fully enclosed automated cell processing system accurately introduces liquid into a piston centrifuge barrel through centrifugal units, pneumatic devices, load cells, etc., and achieves gradient separation of different components under the action of centrifugation.

The company will use the series B+ funding to promote the commercial application of lentiviral vector (LVV) large-scale production technology, the research and development of adeno-associated virus vector (AAV) large-scale production technology, as well as the optimization and expansion of the overall solution for cell drug production automation market.

## Funding rounds

- Series B, Feb 21, 2024, $42M — Eight Roads Ventures, Guangdong Technology Financial Group, Fortune Capital, ABC Capital, Yuexiu Industrial Investment Funds Management, Tasly Capital Holdings Limited, Yuewan Huasheng Capital
- Series B, Jun 1, 2022 — Eight Roads Ventures, Juffett Capital, Juke Investment
- Series A, Apr 23, 2021 — Ming Capital
- Series A, Oct 12, 2020 — Tsing-Yuan Capital

## Investors

- Tsing-Yuan Capital (https://capitalatlas.ai/funds/tsing-yuan-capital) — Series A
- Ming Capital — Series A
- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series B
- Juffett Capital (https://capitalatlas.ai/funds/juffett-capital) — Series B
- Juke Investment — Series B
- Guangdong Technology Financial Group (https://capitalatlas.ai/funds/guangdong-technology-financial-group) — Series B
- Fortune Capital — Series B
- ABC Capital (https://capitalatlas.ai/funds/abc-capital) — Series B
- Yuexiu Industrial Investment Funds Management (https://capitalatlas.ai/funds/yuexiu-industrial-investment-funds-management) — Series B
- Tasly Capital Holdings Limited (https://capitalatlas.ai/funds/tasly-capital-holdings-limited) — Series B
- Yuewan Huasheng Capital (https://capitalatlas.ai/funds/yuewan-huasheng-capital) — Series B